期刊
INTERNATIONAL JOURNAL OF CARDIOLOGY
卷 221, 期 -, 页码 567-571出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2016.06.204
关键词
Acute coronary syndrome; Morphine; Platelet aggregation inhibitors; Myocardial infarction
资金
- Daiichi Sankyo/Eli Lilly
- AstraZeneca
- Bayer
- Medicine Company
- Boehringer Ingelheim
- Daiichi Sankyo
- Eli Lilly
Background: Morphine is frequently used in ST-segment elevation myocardial infarction (STEMI) patients, even if recently it has been associated with a delayed onset of action of the oral antiplatelet agents. There are no data regarding the impact of morphine on myocardial reperfusion after primary percutaneous coronary intervention (PPCI). Objective: This study sought to assess myocardial reperfusion by early ST-segment resolution (>= 50% at 30 minutes) according to morphine use in STEMI patients undergoing PPCI. Methods: 182 STEMI patients undergoing PPCI and receiving either prasugrel (n=51) or ticagrelor(n=131), who were antiplatelet and anticoagulant therapies naive, were included in the study. All patients had serial ST-segment elevation evaluations by ECG and residual platelet reactivity assessments by VerifyNow P2Y12 Reactivity Units (PRU). Results: Overall, 74 (41%) patients received morphine according to the attending physician's preference and showed lower ST-segment resolution rate as compared with patients without morphine (76% vs 87%, p = 0.047). Higher baseline TIMI flow < 2 rate (79% vs 64%, p = 0.036) and peak CPK values (1821 [924-3283] U/L vs 1483 [718-2327] U/L, p = 0.034) were observed in morphine patients. Moreover, a delayed response to oral antiplatelet (PRU area under the curve [AOU0-8]: 1448 +/- 448 vs 686 +/- 292, p = 0.001) was documented in patients with morphine as compared with those without. The independent predictors of early ST-segment elevation resolution failure were PRU = 208 after antiplatelet loading (OR 2.78, 95% CI 1.08-7.14; p = 0.034) and TIMI flow grade <3 after PPCI (OR 5.89, 95% CI 1.64-21.12; p = 0.009), but not morphine use. Conclusions: In STEMI patients undergoing PPCI, morphine use is associated with a higher residual platelet reactivity and a poorer myocardial reperfusion. Independent predictors of impaired myocardial reperfusion were high residual platelet reactivity and TIMI flow grade after PPCI but not morphine use, questioning the direct relationship between morphine and worse myocardial reperfusion. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据